PE Ratio
31.29
+0.02+0.06%
Wed, 26 Feb 2025 09:14:06 GMT
Summary
- As of February 26, 2025, SUPN price to earnings ratio is 31.29, with a rise of +0.02 (+0.06%) during the most recent trading day.
- SUPN PE ratio is now -92.03% below its all-time high of 392.41.
Performance
SUPN PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PE Ratio Formula
P/E = Price
TTM Earnings Per Share
Price
TTM Earnings Per Share
TTM Earnings Per Share
SUPN PE Ratio Trends
PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
---|---|---|---|---|
todaytoday | +0.1% | +0.1% | +1093.8% | +3.5% |
1 m1 month | -10.6% | -10.6% | - | - |
3 m3 months | -10.1% | -10.1% | 0.0% | 0.0% |
6 m6 months | -92.0% | -4.0% | - | - |
ytdytd | -7.5% | -7.4% | - | - |
1 y1 year | - | +9.9% | +160.9% | +6.8% |
5 y5 years | +238.3% | +71.5% | +160.9% | +6.8% |
SUPN PE Ratio Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -16.7% | 30.55 | +2.4% | |
3 m | 3-month | 37.57 | -16.7% | 30.55 | +2.4% |
6 m | 6-month | 392.41 | -92.0% | 28.75 | +8.8% |
1 y | 1-year | 392.41 | -92.0% | 28.75 | +8.8% |
3 y | 3-year | 392.41 | -92.0% | 19.48 | +60.6% |
5 y | 5-year | 392.41 | -92.0% | 6.85 | +356.8% |
alltime | all time | 392.41 | -92.0% | 1.62 | +1831.5% |
Supernus Pharmaceuticals PE Ratio History
Date | Value |
---|---|
2025 | 31.29(-7.5%) |
2024 | 33.81(-2.4%) |
2022 | 34.63(+16.4%) |
2021 | 29.76(+179.2%) |
2020 | 10.66(-5.2%) |
Date | Value |
---|---|
2019 | 11.24(-30.3%) |
2018 | 16.13(-57.1%) |
2017 | 37.59(+153.1%) |
2016 | 14.85(-69.1%) |
2015 | 48.00 |
FAQ
- What is Supernus Pharmaceuticals price to earnings ratio?
- What is the all time high PE ratio for Supernus Pharmaceuticals?
- What is SUPN price to earnings ratio year-to-date change?
What is Supernus Pharmaceuticals price to earnings ratio?
The current PE ratio of SUPN is 31.29
What is the all time high PE ratio for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high price to earnings ratio is 392.41
What is SUPN price to earnings ratio year-to-date change?
Supernus Pharmaceuticals price to earnings ratio has changed by -2.52 (-7.45%) since the beginning of the year